MENU
+Compare
CBSC
Stock ticker: OTC
AS OF
Dec 11 closing price
Price
$0.03
Change
-$0.01 (-25.00%)
Capitalization
4.15M

CBSC Cardiac Biotech Solutions Inc. Forecast, Technical & Fundamental Analysis

Cardiac Biotech Solutions Inc, through its U... Show more

CBSC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CBSC with price predictions
Dec 11, 2025

CBSC's RSI Indicator slumps oversold zone

The RSI Oscillator for CBSC moved into overbought territory on December 11, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for CBSC moved above the 200-day moving average on November 21, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CBSC advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

CBSC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CBSC as a result. In of 127 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CBSC turned negative on December 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 63 similar instances when the indicator turned negative. In of the 63 cases the stock turned lower in the days that followed. This puts the odds of success at .

CBSC moved below its 50-day moving average on November 18, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for CBSC entered a downward trend on November 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CBSC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (9.341). P/E Ratio (0.000) is within average values for comparable stocks, (161.290). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.528). CBSC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (53.763) is also within normal values, averaging (111.323).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBSC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CBSC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
10845 Griffith Peak Drive
Phone
+1 888 225-0870
Employees
4
Web
https://www.cbscientificinc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZH22.780.18
+0.80%
Beazer Homes USA
PELI10.150.04
+0.40%
Pelican Acquisition Corporation
HSCS2.62N/A
N/A
HeartSciences Inc
PODD294.17-1.02
-0.35%
Insulet Corp
TLX9.37-0.55
-5.54%
Telix Pharmaceuticals Ltd.

CBSC and Stocks

Correlation & Price change

A.I.dvisor tells us that CBSC and LNSR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBSC and LNSR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBSC
1D Price
Change %
CBSC100%
-30.28%
LNSR - CBSC
20%
Poorly correlated
-0.43%
CALZF - CBSC
6%
Poorly correlated
+11.47%
BBLG - CBSC
3%
Poorly correlated
-9.16%
BLOZF - CBSC
3%
Poorly correlated
-1.11%
CHEOF - CBSC
1%
Poorly correlated
N/A
More

Groups containing CBSC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBSC
1D Price
Change %
CBSC100%
-30.28%
Pharmaceuticals
category (377 stocks)
2%
Poorly correlated
+0.72%
Pharmaceuticals: Other
category (103 stocks)
1%
Poorly correlated
-0.21%